A Japanese clinic that offers regenerative treatment should be able to answer a short set of basic questions clearly and in writing. The questions below follow the order of a typical consultation. For each one, this article explains why it matters and what a satisfactory answer looks like. You do not need a medical background to ask them, and a clinic that cannot answer them is giving you useful information.

Ask the questions before you travel, and ask for the answers in writing where you can. A written reply is easier to compare and keep than a conversation.

1. Has this treatment been filed under the Act, and which class is it?

Why ask: Under the Act on the Safety of Regenerative Medicine, a clinic must file a provision plan for each treatment with the Minister of Health, Labour and Welfare before it provides that treatment. Filing is per treatment, so a plan for one procedure says nothing about another. Providing a treatment without a filed plan is a violation of the Act.

A satisfactory answer: The clinic gives the name of the procedure, the class it has filed under, and confirms that a plan has been submitted and accepted. For donor-derived or iPS-derived cells, the class is Class I. For cultured cells from the patient's own body, it is usually Class II. For many other techniques, such as some immune cell therapies, it is usually Class III. The filed plan decides, not the marketing.

2. Which review committee approved the plan?

Why ask: Every plan must be reviewed by a certified regenerative medicine committee before filing. Class II plans must be reviewed by a specially certified committee under Article 11 of the Act.

A person in a light blue short-sleeved top reaches into a clear bin in a wall-mounted medical supply organizer.

A satisfactory answer: The clinic names the committee. If the treatment is Class II, the committee should be a specially certified one. If the clinic describes a Class II treatment but names a committee that reviews only Class III, the two do not match.

3. Who will examine me and carry out the treatment?

Why ask: The Act requires the clinic to name the person responsible for the treatment and the physicians who provide it. The person who greets you at reception is not always the physician who treats you.

A satisfactory answer: The clinic gives the names of the responsible physician and the treating physician in writing, and a physician examines you in person to decide whether the treatment is suitable.

4. What cells are used, and where do they come from?

Why ask: The cell source determines the class, the procedure and the cost. Donor cells are different from your own cells, and cultured cells are different from cells used directly.

A satisfactory answer: The clinic states the source (for example, your own fat or blood, or donated umbilical cord tissue), whether the cells are cultured, how many treatments are given and over what period. The answer should match the class given in question 1. If the clinic describes donor cells but files them as Class II or III, ask why.

5. Where are the cells processed, and by whom?

Why ask: Processing is where quality risk is concentrated. When a clinic uses an outside facility, the Act requires that facility to be a licensed or registered specified cell processor, and the filed plan must name it.

A satisfactory answer: The clinic says whether processing is in-house or external, and names the external facility if there is one. It can explain how cells are tested for quality before release, and how they are transported and stored.

6. What are the expected benefits, and what are the risks?

Why ask: An explanation of expected benefits and disadvantages is a required part of informed consent under Article 14 of the Act. A presentation that describes only the upside is incomplete.

A person in a lab coat, face mask, hairnet, and blue gloves uses a small tool to handle items in a rack of small containers in a laboratory.

A satisfactory answer: The clinic describes what benefit it expects, what side effects are common and which are serious, such as pain or infection at the collection or injection site. It also says how strong the evidence is for the condition you have. Be cautious of claims that a treatment is certainly effective or has no side effects. Filing a plan confirms the legal process was followed; it does not confirm that the treatment works.

7. What other options do I have?

Why ask: Article 14 requires a physician to give an appropriate explanation of the treatment, and in practice this includes the alternatives. A physician who is confident in a treatment will still place it among the options.

A satisfactory answer: The clinic can describe standard treatment or other options for your condition and compare their benefits and risks with the regenerative treatment. An answer that says only this treatment is possible deserves a second opinion.

8. What will it cost in total, what is included, and what happens if I stop?

Why ask: Regenerative treatment in Japan is generally self-pay. The clinic sets the price, and the patient pays the whole amount. Costs are part of the information that should be explained before consent.

A satisfactory answer: The clinic gives a written breakdown: consultation and tests, collection, processing, each administration, any hospital stay, and follow-up. It states how many treatments are planned and what is charged separately. It explains what happens to payments if you withdraw consent or if the physician decides treatment should stop, and who pays for any complication treatment.

9. If I feel unwell after I go home, who do I contact, and what happens?

Why ask: Clinics must be able to follow patients after treatment, and serious adverse events must be reported within fixed deadlines: 7 days for deaths or cases that may lead to death, and 15 days for other serious cases (Article 35 of the Enforcement Regulations).

A satisfactory answer: The clinic sets out a follow-up plan: when you should be checked after returning home, what is checked, how results are sent, and who you contact if something goes wrong, with response times. It should also be able to say how a local doctor can communicate with its team. Ask for a copy of your records, reports and treatment notes before you leave Japan.

10. If I change my mind, or I want to make a complaint, what happens?

Why ask: Consent must be voluntary, and you are entitled to change your mind. A clinic should also have a channel for complaints and consultations, and you should know how to reach it.

A satisfactory answer: The clinic explains in writing how to withdraw consent and by when, what happens to costs already incurred, and gives the contact for its complaint and consultation desk.

How to use this list

Send the questions in advance. Sending them before the consultation and asking for written answers gives you a record and lets the clinic prepare.

A doctor in a white coat with a stethoscope sits at a desk with a clipboard and computer, facing a person seen from behind.

Compare the consent document with the ten questions. Before you sign, read the explanation document and tick off each of the ten points. If something is missing, ask for it to be added.

Compare the answers. The answers to questions 1 and 4 should match each other. If the clinic's account of the cell source does not fit its stated class, or if it avoids written answers, be careful.

Ask for the consent document in a language you read. The explanation document is usually in Japanese. Have it checked line by line by someone who reads Japanese, or ask for a translation before you sign. Ask for anything you do not understand to be explained again before you sign.

If you would like help with this, you can send the clinic's name and the treatment you are being offered to our advisors. They can help you organize the questions and check whether the treatment appears in a filed plan. Stem Cell Japan provides consultation and coordination for regenerative medicine in Japan; treatment itself is provided by Japanese medical institutions. For the overall process, read Medical tourism in Japan: a step-by-step guide. For the rules behind these questions, read How Japan regulates regenerative medicine.

Frequently asked questions

If a clinic says a filing is not needed, should I believe it?

Ask why. Regenerative treatments that a clinic provides generally require a filed provision plan. If the clinic says the treatment falls into a different category, ask it to name the category and the legal basis, and ask for the answer in writing.

Do these questions offend doctors?

They should not. Most of the information asked for is information a physician must already provide in writing before consent. A compliant clinic has an explanation document ready.

If the answers all seem satisfactory, does that mean the treatment will work?

No. The questions help you confirm that the clinic has completed its legal steps and explained the treatment. Whether the treatment is suitable for you, and what result you might see, must be decided by a doctor after an in-person examination, and results vary between people.

Sources: Act on the Safety of Regenerative Medicine (Act No. 85 of 2013), Articles 4, 11 and 14 (e-Gov, laws.e-gov.go.jp); Enforcement Regulations, Articles 2, 3 (classification), 6 (emergency capacity) and 35 (reporting deadlines) (e-Gov); MHLW, "Regenerative medicine, cell medicine and gene therapy" page (updates to September 2026). Checked November 2026; MHLW publications prevail.

Medical disclaimer: This site provides general information only and does not constitute medical advice; whether any treatment is suitable for you must be decided by a doctor after an in-person consultation.